hydromorphone hydrochloride
- Product NDC
- 43602-266
- 11-digit product format
- 436020266
- Labeler code
- 43602
- Product ID
- 43602-266_728caa01-5e35-4d0e-b15a-d716cd48c34f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydromorphone hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Ascent Pharmaceuticals, Inc.
- Application
- ANDA212133
- Marketing category
- ANDA
- Marketing start
- 2020-09-24
- Marketing end
- 0000-00-00
- Substance
- HYDROMORPHONE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43602-266 | HYDROMORPHONE HYDROCHLORIDE TABLET, EXTENDED RELEASE [ASCENT PHARMACEUTICALS, INC.] | 3 | Legacy NDC | 20201016_59b1e29f-3292-422c-bfdc-56803436c0ba.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43602-266-05 | 43602026605 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-266-05) | 2020-09-24 | 0000-00-00 | No | No | Current |
| 43602-266-30 | 43602026630 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-266-30) | 2020-09-24 | 0000-00-00 | No | No | Current |